Skip to main content
. 2020 Dec 23;6(12):e05815. doi: 10.1016/j.heliyon.2020.e05815

Figure 5.

Figure 5

PBMCs treated with SLE-MPs and CMPs show reduced levels of IκBα and cytoplasmic p65, and PDTC inhibits this reduction. Representative immunoblots are shown for IκBα (a) and p65 (b). Densitometry analysis of the levels of the IκBα (c) and the cytoplasmic p65 protein (d) expressed as the fold change with respect to unstimulated cells. β-actin protein immunoblot was performed to ensure equal sample loading. Results are shown as media ± range. Data were compared using two-way ANOVA; n = 5.